Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy.

Abstract

Presented here are two cases of multidrug-resistant Nocardia farcinica infection that occurred in immunocompromised patients. One of the patients developed the infection despite being on trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis jiroveci. These cases demonstrate the propensity of Nocardia spp. to cause disseminated disease and to develop resistance to multiple antimicrobial agents used in the initial treatment of serious Nocardia infection. These factors lead to the conclusion that empiric monotherapy with trimethoprim/sulfamethoxazole may not be sufficient. Treatment with a combination regimen of imipenem and amikacin may be a more promising initial therapy.

• Authors: W Hitti, M Wolff
• Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis) Vol. 24 Issue 2 Pg. 142-4 (Feb 2005) ISSN: 0934-9723 [Print] Germany
• PMID: 15692815 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antifungal Agents
• Trimethoprim, Sulfamethoxazole Drug Combination

Topics

• Aged
• Aged, 80 and over
• Antibiotic Prophylaxis
• Antifungal Agents (pharmacology, therapeutic use)
• Drug Resistance, Multiple, Fungal
• Female
• Humans
• Immunocompromised Host
• Male
• Nocardia (classification, drug effects)
• Nocardia Infections (microbiology)
• Pneumonia, Pneumocystis (prevention & control)
• Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)